Board Meeting For The Audited Financial Results For The Quarter And Financial Year Ended March 31, 2017 As On May 6, 2017 And Intimation Of Closure Of Trading Window
Board Meeting for the Audited Financial Results for the quarter and financial year ended March 31, 2017 as on May 6, 2017 and intimation of Closure of Trading Window CERTIFICATE UNDER REGULATION 40 (9) OF SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE HALF YEAR ENDED 31ST MARCH, 2017 - PFIZER LIMITED
CERTIFICATE UNDER REGULATION 40 (9) OF SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE HALF YEAR ENDED 31ST MARCH, 2017 - PFIZER LIMITED Shareholding for the Period Ended March 31, 2017
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended March 31, 2017
Statement for the quarter ended March 31, 2017, under Regulation 13 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 1.Investor complaints pending at the beginning of the quarter - NIL 2.Investor complaints received during the quarter - 17 3.Investor complaints disposed of during the quarter - 17 4.Investor complaints remained unresolved at the end of the quarter - NIL... Compliance Certificate For The Half Year Ended March 31, 2017.
CERTIFICATE UNDER REGULATION 7(3) OF THE SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE HALF YEAR ENDED ON 31st MARCH, 2017 We hereby certify that all the activities in relation to both physical and electronic share transfer facility are maintained by M/s. Karvy Computershare Private Limited, Registrar & Share Transfer Agent holding requisite certificate as Category I Registrar & Share Transfer Agent vide SEBI Registration... Clarifies on News item
With reference to news flashed on CNBC TV18 dated March 24, 2017 quoting "Pfizer's Hospira Vizag Unit Receives 11 observation from US FDA.", Pfizer Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Pfizer Ltd
The Exchange has sought clarification from Pfizer Ltd on March 24, 2017, with reference to news flashed on CNBC TV18 dated March 24, 2017 quoting "Pfizer's Hospira Vizag Unit Receives 11 observation from US FDA."The reply is awaited. Alembic Pharma's partner launches drug for depressive disorder
These are therapeutically equivalent to Pristiq of Pfizer Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Birla Sun Life Asset Management Company Ltd Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Birla Sun Life Asset Management Company Ltd